Iradimed Company Insiders

Iradimed Management Team Effectiveness

The company has return on total asset (ROA) of 0.1487 % which means that it generated a profit of $0.1487 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2331 %, meaning that it created $0.2331 on every $100 dollars invested by stockholders. Iradimed's management efficiency ratios could be used to measure how well Iradimed manages its routine affairs as well as how well it operates its assets and liabilities. As of January 29, 2026, Return On Tangible Assets is expected to decline to 0.17. In addition to that, Return On Capital Employed is expected to decline to 0.24. At present, Iradimed's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Deferred Long Term Asset Charges is expected to grow to about 1.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 200 K. The current year's Net Income Applicable To Common Shares is expected to grow to about 15.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 13.1 M. The market capitalization of Iradimed is $1.25 Billion. Over half of Iradimed's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run. Some institutional investors establish a significant position in stocks such as Iradimed in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Iradimed, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Iradimed Workforce Comparison

Iradimed Profit Margins

The company has Profit Margin (PM) of 0.26 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Iradimed Insider Trading History

Iradimed Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Iradimed often depends on how effective the management is. Iradimed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Iradimed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Iradimed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Iradimed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Iradimed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Iradimed's management manipulating its earnings.

When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.